Blue Horseshoe Stocks: Options, MILL Recaps & More

Miller Energy Resources, Inc. MILL

More often than not, when highlighting a stock that has recently recorded a new 52-week low, we’ve had very good fortune- yesterday’s premarket tag of MILL was no exception. It had just registered its annual bottom on Tuesday, and it set us up to bear witness to quite a respectable rebound.

From a low of .26, MILL surged as high as .38, marking an intraday pop of 46% and it happened on just over six times the 3-month average trading volume.

The move came in conjunction with an interesting sequence of events-Tuesday the company announced its significant doubt of its ability to continue as a going concern, which is what brought it to a new 52-week low. We caught it on the news scanner yesterday with a more positive message, regarding the receipt of a $33M tax credit from the State of Alaska and a potential loophole on the company’s debt in the form of a possible loan.

From this point forward we’d suggest an added note of caution pertaining to MILL on account of these somewhat mixed signals. The company is still in danger of filing for bankruptcy, but for our purposes, it turned out to be a nice mid-week bottom-play.

NuGene International, Inc. NUGN

We also wanted to point to another PR that hit the wires yesterday on a stock that we’ve been monitoring this summer. Back on June 15th, we tagged NUGN for observation and watched as it ran from 2.67-3.88 (+47%).

This week, after pulling back to find support at a low of 2.55, NUGN is rebounding back past the $3 mark. We’re going to want to watch it into next week, especially after the exposure that it’s set to receive this weekend.

Per a PR released yesterday the world-famous Kathy Ireland, whose namesake products NUGN distributes, will be doing a special on Fox Business Network (Sunday, 5:30pm ET) and Bloomberg International (Sunday, 8:30am CET, 3:00pm HKT, and 10:30am CDT). It’s called Worldwide Business with kathy ireland® and it will introduce a new line of stem cell-based skincare products. >> VIEW PR

Options Recap

It may be hard for some of our newer subscribers to believe, but most of the options calls we made yesterday morning ended up yielding chances at double-bag gains! Our regular readers won’t be surprised at all, as we routinely formulate such opportunities for options daytrades.

FitBit, Inc. FIT

All of the FIT Options ideas we signaled (Weekly $45.50-48 Calls) yesterday gave us the chance for notable gains, with the most significant action coming from the $46-48’s.

The $46 Calls initially ran 192% from 1.06-3.10, then dipped to a low of .79 before rebounding to 1.85 for an added 134% swing. 

The $47’s first burst carried them from .96-2.24 (+133%) dipped to .45 closed at 1.20 (+166%)

$48 Calls went on a 93% run from .88-1.70, and pulled back to .40 before ripping back to .75 for a chance at an extra 87% gain.

___

Netflix, Inc. NFLX

Our ideas for NFLX Weekly $100-105 Calls are figuring to turn out quite nicely as well before the week is out.  In the image below we can see the closing prices on all of those contracts; with NFLX trading above $110 in the premarket, we expect to see all of those prices increased significantly as they’re pushed deeper into the money. We’ll be on the lookout for dip-and-rip scenarios for the remainder of the week and may consider rolling our strike prices up closer to the money, perhaps somewhere in the 107.14-111.43 range in the event the uptrend continues.

Extended Watchlist:
FCEL, OHRP, PIRS, MNGA, EXEL, ANR(watching for eventual bottom)

Blue Horseshoe Stocks: TBIO Review & More

Transgenomic, Inc. TBIO

TBIO was included in yesterday’s morning report, and the stock recorded a notable session with the help of a favorable press release. The stock started out from an early low of 1.58, and ran 29% to 2.04, dipped back to 1.77 before going on to hit its high of day at 2.11, an added 19% swing. Volume was immense, to the tune of more than nine times the 3-month average.

The news release from yesterday was pertaining to the company’s claim that they’ve developed the most comprehensive test to date for the diagnosis of Leukodystrophy, a disorder that has been notoriously difficult to diagnose; in many cases taking years. >>VIEW PR

There are a number of attractive features of the TBIO chart even after the considerable run it has enjoyed over the past few days- The strengthening RSI just broke the 50-line, and the MACD is gearing up for a bullish cross.


We’ll look for TBIO to continue registering higher lows, preferably above the 50DMA of 1.76, and for it to test resistance in the channel between yesterday’s high of 2.11 and the 200DMA of 2.15. TBIO certainly has a history of making breakout-type moves; twice this year the stock has traded for more than 3.50.

New Options Ideas

We’ve identified a couple of fresh options ideas to pass along to our readers this morning. For each of the following movers, we’ll be on the lookout for the occurrence of a dip-and-rip scenario Both stocks are gapping up here in the premarket.

FitBit, Inc. FIT

For FIT, we are going to monitor Weekly Calls (Friday Expiration) in the $45.50-48 range. We want to pay close attention to them the next couple of sessions as FIT has been establishing higher highs and higher lows on the chart. We’re watching for a dip from profit-taking, and subsequent rebound. If and when that happens, we should see some nice action in the range we highlighted.

Netflix, Inc. NFLX

As for NFLX, which has brought us serious options trading success in the past, we’re going to look for chances in Weekly Calls priced from $100-105. The stock just underwent a forward split, and there is some precedent for price increases following such an event (e.g. AAPL).

Extended Watchlist:
CLSN, OGXI, ATNM, FRO, ARNA, MILL(News)

Blue Horseshoe Stocks: CLTX Recap & More

Celsus Therapeutics Plc. CLTX

The big winner from yesterday’s report turned out to be CLTX. We tagged the stock after catching it on a routine news scan; the company announced an all-stock exchange agreement with Volution Immuno Pharmaceuticals in which CLTX will absorb the company as a wholly-owned subsidiary, and form a new company aimed at developing treatments for a range of rare and orphan autoimmune and inflammatory diseases >> READ PR

Back in February, a bleak annual report led CLTX to fall off of a cliff, tumbling from the $6+ range down to roughly a dollar. Over the next several months, the stock continued to trend downward, culminating in a 52-week low of .40 at the end of May. Since that time, it received a little boost, rising to the .60-range.

That’s where we came upon it yesterday, and it was fortunate that we began paying attention when we did. After dipping to a daily low of .5012, the stock ran into the close, reaching a high of .68; a solid 36% intraday move. The late boost of momentum is carrying over into the premarket today, with CLTX hitting an early high of .99. From our observed low yesterday, that’s a 98% swing.

We’ll look for it to continue to build its base with higher lows, and to potentially crack through resistance into dollar-territory.

Callaway Golf Co. ELY

ELY is contributing to the newsreel this morning, announcing the signing of a highly talented young golfer. Upon taking notice of this, we’ve also seen that ELY has been building a heck of a chart setup over the past few sessions.

The stock has registered higher lows for each of the last four consecutive trading sessions, and is exhibiting a great deal of promise with regard to a number of bullish signals on the chart that we’ve pointed out on the snapshot below. Between that, and it being the peak of golf season, we’ll be paying close attention to ELY.

CARLSBAD, Calif., July 14, 2015 /PRNewswire/ — Today Callaway Golf officially announced that it has reached a Staff Pro agreement with former college golf phenom, Julien Brun. A native of Anitbes, France, Brun turns pro after an unbelievable career at Texas Christian University (TCU), where he was a 3-time First Team All-American and a 3-time Academic All-American.>> FULL PR

EnteroMedics, Inc.  ETRM

Speaking of ripening charts, we’ve got to tag ETRM this morning as a bottom-play that could be in line for a serious rebound. One look at the chart is all it takes to see what we mean.

We’ve got an egregiously oversold RSI, and the stock has fallen to new 52-week lows in the past couple of sessions.  There are also a couple of gaps to fill from 44-.50 and from .83-.96 on a possible retrace, so we’ll be monitoring this play which we feel has breakout potential based on these factors.

Extended Watchlist:
BIOC, CLSN, TBIO, CEL, VLTC, CPXX

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Solaris Power Cells, Inc. SPCL

We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.

Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.

In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:

PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL)  the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR

OncoGenex Pharmaceuticals, Inc OGXI

OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.

BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR


Frontline, Ltd. FRO

We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.

An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE

Extended Watchlist:
PSDV, GILT, FREE, GRPN, DANG, CLTX, DRYS

Blue Horseshoe Stocks: Late-Breaking PZOO News

Pazoo, Inc. PZOO

For those of our subscribers who may have missed our after hours highlight of PZOO‘s post-market PR yesterday, it alluded to the signing of Pazoo subsidiary CannabisKing’s second distribution deal in as many weeks. The company has obtained the rights to distribute Grow Pure Systems™ full product line >> VIEW PR We had also tagged the stock in our premarket extended watchlist as a bottom-watch play, and it did make a solid 14% intraday move from .0057-.0065.

We’ve already seen PZOO make a couple of more serious swings from the subpenny range to .015 or better back in April and May, so we’re well aware of its ability to make rapid gains. It is being demonstrated once again this morning, as PZOO shot to a high of .0099, running into resistance just shy of the 50DMA (.01); that’s a two-session swing of 74% over yesterday’s low!

That combined with  three significant news releases over the past 24 hours, puts our focus squarely on PZOO as we wrap up another trading week, and will surely make it a point of interest heading into next week as well.

Late-breaking news from PZOO this morning just hit the wires and it outlines a third distribution agreement for its CannabisKing subsidiary, which is increasing its portfolio at an impressive rate:

WHIPPANY, N.J., July 10, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#: A1J3DK), 100% wholly owned subsidiary CannabisKing Distribution, LLC, has signed a deal with MJPayment, LLC, to sell their Banking Solution Services throughout the region where Pazoo labs are being opened. MJPayment has developed an innovative and powerful payment and banking suite as well as an industry first bank compliance solution for the legal marijuana industry. >> FULL PR

Get Our FREE Daily Reports!

SUBSCRIBE